Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NeoGenomics Laboratories, Inc. ×

NeoGenomics Laboratories, Inc.

This institution is selected. Its supporting articles are shown below.

NeoGenomics Laboratories, Inc.1

Articles mentioning NeoGenomics Laboratories, Inc.

1 articles · page 1 of 1

91 Metabolic reprogramming in RCC tumors contributes to a dysfunctional immune response within the tumor microenvironment and is correlated with disease progression

jitc · abstract · 2025-11-04 · 1 matching annotations

83.3%

NeoGenomics Laboratories, Inc.renal cell carcinoma Renal cell carcinoma (RCC)immunotherapy

…we incorporated the new PaletrraTM end to end spatial workflow (NeoGenomics Laboratories, Inc.) and developed a panel that includes: CD3, CD4, CD8, FoxP3, CD6…

Browse institutions

NeoGenomics Laboratories, Inc.

Articles mentioning NeoGenomics Laboratories, Inc.

91 Metabolic reprogramming in RCC tumors contributes to a dysfunctional immune response within the tumor microenvironment and is correlated with disease progression